期刊文献+

抗癌大环化合物的环合方法

Ring Closure Approaches Toward the Synthesis of Anticancer Macrocyclic Compounds
下载PDF
导出
摘要 大环化合物具有广泛的生物活性。一些具有抗癌活性的天然大环化合物已开发成上市药物或应用于临床研究。在抗癌大环化合物的合成中,环合步骤是整个合成过程中的关键,同时也是难点所在。目前已经发展出了一些方便实用的环合方法。文章以具有抗癌作用的大环化合物为例,简要介绍各种常用的大环环合方法及应用。 Macrocyclic compounds continue to capture attention from academic for their diversity biological activities.Great efforts have been devoted to explore practical methods for the macro-ring cyclization,which is,in most cases,the key step in the syntheses of diverse purposes.Many useful and convenient methods or preparations have been discovered,such as the ring closure metathesis(RCM),the Pd-catalyzed coupling reaction,the lactamization and lactonization reaction.Herein a brief review of these approaches as well as their application will be presented.
出处 《广州化学》 CAS 2011年第1期46-58,共13页 Guangzhou Chemistry
基金 国家自然科学基金项目(30873137)
关键词 大环化合物 环合方法 抗癌活性 催化剂 反应机理 macrocyclic compounds ring closure approaches anticancer biological activities catalyst reaction mechanism
  • 相关文献

参考文献49

  • 1Adriana B da Rocha, Rafael M Lopes, Gilberto Schwartsmann. Natural products in anticancer therapy[J]. Cancer, 2001, 1: 364-369.
  • 2Tadeusz F Molinski, Doralyn S Dalisay, Sarah L Lievens, et al. Drug development from marine natural products[J]. Drug Discovery, 2009, 8: 69-85.
  • 3Alejandro M S Mayer, Kirk R Gustafsonb. Marine pharmacology in 2003-2004: Anti-tumour and cytotoxic compounds[J]. Eur J Cancer, 2006, 42: 2241-2270.
  • 4Alejandro M S Mayer. Marine pharmacology in 2005-2006: Anti-tumour and cytotoxic compounds[J]. Eur J Cancer, 2008, 44: 2357-2387.
  • 5Mani S, Swami U. Eribulin mesilate, a halichondrin B analogue, in the treatment of breast cancer[J]. Drugs Today(Barc), 2010, 9(46): 641-653.
  • 6http://www.druglib.com/druginfo/istodax. 2009-11-06.
  • 7http://www.cancer.gov/cancertopics/druginfo/fda-ixabepilone. 2007-10- 17.
  • 8Gary Hudes M D, Michael Carducci M D, Piotr Tomczak M D, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma[J]. N Engl J Med, 2007, 22(356): 2271-2280.
  • 9Maurizio D'Incalci, Carlos M Galmarini. A Review of trabectedin(ET-743): A unique mechanism of action[J]. Mol Cancer Ther, 2010, 9(8): 2157-2163.
  • 10M Broggini, S V Marchini, E Galliera, et al. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autoerine loop in human leukemia cells MOLT-4[J]. Leukemia, 2003, 17(1): 52-59.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部